Recurrent fusions in PLAGL1 define a distinct subset of pediatric-type supratentorial neuroepithelial tumorsPhilipp Sievers, Pascale Varlet, Sophie C. Henneken et al.|Acta Neuropathologica|2021Cited by 81
GOPC:ROS1 and other ROS1 fusions represent a rare but recurrent drug target in a variety of glioma typesPhilipp Sievers, Felix Sahm, Damian Stichel et al.|Acta Neuropathologica|2021Cited by 23
Molecular signatures define <i>BAP1</i>-altered meningioma as a distinct CNS tumor with deregulation of Polycomb repressive complex target genesPhilipp Sievers, Felix Sahm, Tibor Hortobágyi et al.|Neuro-Oncology|2025Cited by 14
<i>Distribution of GOPC:ROS1</i> and other <i>ROS1</i> fusions in glioma typesPhilipp Sievers, Felix Sahm, Damian Stichel et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 1
Recurrent fusions in <i>PLAGL1</i> define a distinct subset of pediatric-type supratentorial ependymomaPhilipp Sievers, Wolfgang Wick, Sophie C. Henneken et al.|bioRxiv (Cold Spring Harbor Laboratory)|2021Cited by 0